Tetralogy of Fallot (TOF) is still the most common and complicated cyanotic congenital heart defect 20 of all congenital heart diseases with a 10% incidence. Surgery repair is often necessary in infancy. 21
The total incidence of neonatal defects in China is 5.6%, and 0.9 million neonates are born with 37 defects every year. The incidence of neonatal defects is increasing annually. The heart is the first 38 major internal organ in the process of embryogenesis and is important for the survival of an embryo. 39 Congenital heart disease (CHD) has ranked first for five consecutive years in neonates. The overall 40 incidence of CHD in the population is 1‰-13‰. In China, the incidence of CHD is 4‰-8‰. 41 Children with severe CHD die in childhood, thereby causing psychological trauma and economic 42 burden to families and society. Tetralogy of Fallot (TOF) remains the most common complex 43 cyanotic congenital heart defect among all congenital heart diseases given its 10% incidence 44 (BEDARD et al. 2009 ). Surgery repair is often necessary in infancy, and the perioperative mortality is 45 less than 5%. However, long-term follow-up has shown that patients who have undergone total repair 46 of TOF are often at high risk for restenosis of the right ventricular outflow tract (RVOT), pulmonary 47 regurgitation, and ventricular dysfunction, and late sudden cardiac death may occur in 0.5% to 6% of 48 patients due to ventricular tachycardia or other unknown causes (MASSIN et al. 2011; ZHANG et al. 49 2013; LATUS et al. 2015 ; SHIN et al. 2016 ) . The exact etiology of TOF remains unclear, and its 50 pathogenesis is complex. Genetic and epigenetic mechanisms, such as chromosomal abnormality, 51 gene mutation, nucleic acid modification, noncoding RNA (ncRNA), and circular RNA (circRNA), 52
play an important role in its occurrence. At present, chromosomal abnormalities, gene mutations, and 53 other genetic mechanisms have been deeply studied and widely used in the diagnosis and treatment 54 of clinical diseases. However, the action mechanism of ncRNAs on TOF needs to be further studied. 55
Recently, genome-wide transcriptional studies have represented that only almost 1% of the 56 human genome produces biologically meaningful RNA transcripts, while a much larger proportion of 57 the genome is transcribed into ncRNAs (PONTING et al. 2009 However, ncRNAs may play a significant regulatory part in heart formation. Little is known 99 regarding the changes in the transcriptome and the possible associations with TOF. Thus, we 100 systematically analyzed the specific lncRNA, miRNA, circRNA, and mRNA profiles of TOF to gain 101 more in-depth knowledge. As we know, no genome-wide study has concentrated on the 102 transcriptome in TOF. This is the first work to obtain meaningful differentially expressed lncRNAs, 103 miRNAs, circle RNA, and mRNAs. 104 105
Materials and methods 106
Subjects 107
The case group included five children with TOF (two boys and three girls, aged 6-22 months). 108
Cyanosis was found in all children, and rough systolic murmur was found between the second and 109 fourth intercostals at the left border of the sternum by auscultation. Echocardiography showed 110 ventricular septal defect, aortic straddle, RVOT obstruction, pulmonary artery stenosis, right 111 ventricular enlargement, and right ventricular anterior wall thickening. The children and their parents 112 had no other intracardiac and extracardiac malformations. In the control group, five fetuses, including 113 three males and two females with gestational age of 25-28 weeks, had normal hearts. Given fetal 114 distress, cord twist, and placental abruption, odinopoeia was conducted. 115
Extraction of RNA 116
The Total RNA including small RNA was collected from 10-20 mg of frozen tissue of the right 117 ventricle by using a TRIzol reagent (Invitrogen, Gaithersburg, MD, USA), which was purified with a 118 mirVana miRNA Isolation Kit (Ambion, Austin, TX, USA) according to the instructions of the 119 manufacturer. RNA's purity and concentration were defined by OD260/280 by using a 120 spectrophotometer (NanoDrop ND-1000). RNA integrity was defined by 1% formaldehyde 121 denaturing gel electrophoresis. RNA integrity was defined by capillary electrophoresis with an RNA 122 6000 Nano Lab-on-a-Chip kit and Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA). 123
Only if the integrity number values of RNA were more than 6, it was analyzed later. 124
Microarray 125
The specific lncRNA, mRNA, miRNA, and circle RNA profiles of TOF were analyzed by using 126
Agilent human lncRNA+mRNA Array v4.0, Agilent human miRNA Array V21.0, and Agilent 127 human circRNA Array v2.0. 128 lncRNA and mRNA profiling was performed using the Agilent human lncRNA+mRNA Array 129 V4.0 designed with four identical arrays per slide(4×180k), which included the number of probes of 130 human lncRNAs and human mRNAs being approximately 34,000 and 41,000 respectively. lncRNA 131 and mRNA target sequences were selected from diverse databases such as GENCODE/ENSEMBL, 132
Human LincRNA Catalog [1], RefSeq, USCS, NRED (ncRNA Expression Database), LNCipedia, H-133
InvDB, LncRNAs-a (Enhancer-like), Antisense ncRNA pipeline, etc.. Repeated probes were used to 134 detect each RNA for two times. The control probes were contained in the array. 135
The Agilent miRNA array (8 × 60K) was used to detect miRNA profiling, which included 2549 136 probes of human mature miRNAs and the miRNA target sequences were from the miRBase R21.0. 137
Repeated probes were used to detect each miRNA for times. The control probes were contained in 138 the array. 139
The Agilent human circRNA Array V2.0 (4 × 180K) was used to detect circRNA profiling, 140
which included approximately 170,340 probes of human circRNAs and the circRNA target 141 sequences were from circBase and DeepBase. Long and short probes were used to detect each 142 circRNA at the same time. The control probes were contained in the array. 143
RNA amplification, labeling, and hybridization 144
Agilent human lncRNA+mRNA Array v4.0 145 Cy5 and Cy3-dCTP was used to label the cDNA) by using the Eberwine's linear RNA amplification 146 method and subsequent enzymatic reaction (PATTERSON et al. 2006 ). By using the CbcScript reverse 147 transcriptase with cDNA synthesis system according to the manufacturer's protocol with T7 Oligo 148 (dT) and T7 Oligo (dN), double-stranded cDNAs were synthesized using 1 µg of total RNA. 149 DNA polymerase and RNase H were used for double-stranded cDNA (dsDNA) synthesis PCR 150
NucleoSpin Extract II Kit eluted with 30 µL elution buffer was used for the purifying of the dsDNA 151 products. The products were concentrate to 16 µL and conducted with vitro transcription reactions in 152 40 µL using the T7 Enzyme Mix at 37 °C for 14 h. the RNA Clean-up Kit was used for purifying the 153 amplified cRNA. 154
Klenow enzyme labeling was performed next by using CbcScript II reverse transcriptase. In 155 short, the amplified RNA (2 µg) was mixed with random nanomer (4 µg), denatured for 5 min at 65 156 °C, and immediately cooled on the ice. Then, 4× first-strand buffer (5 µL), o0.1M DTT (2 µL), and 157
CbcScript II reverse transcriptase (1.5 µL) were mixed and added. The mixtures were incubated for 158 10 min at 25 °C ad then for 90 min at 37 °C. The purification method of cDNA products was as 159
follows. cDNA was added with random nanomer (4 µg), 95 °C for 3 min, and cooled on ice 160 immediately for 5 min. Then, Klenow buffer (5 µL), dNTP, and Cy5-dCTP or Cy3-dCTPwere mixed 161 and added. Then, added Klenow enzyme for1.2 µL, and incubated for 90 min at 37 °C. Labeled 162 cDNA was purifiedas follows. The hybridization solution of the labeled controls samples and test 163 samples were dissolved in 80 µL including 3× SSC, 0.2% SDS, 5× Denhardt's solution, and 25% 164 formamide. DNA in the hybridization solution was denatured at for 3 min 95 °C before loading on 165 the microarray. Arrays were hybridized overnight at 42 °C in an Agilent Hybridization Oven at the 166 rotation speed of 20 rpm. At last, the microarray was washed using the consecutive solutions (0.2% 167 SDS, 2× SSC and 0.2× SSC). 168
Agilent human miRNA Array V21.0 169
The experiments were carried out in accordance with the protocol of the manufacturer. In short, the 170 miRNA labeling reagent was used to label the miRNAs. pCp-Cy3 was used to dephosphorylate and 171 ligate 200 ng total RNA. Next, we purify and hybridize the labeled RNA. Last, the Agilent 172 microarray scanner was used to scan the images and Agilent feature extraction software version 173 10.10 was used to grid and analyze them. 174
Agilent human circRNA Array v2.0 175
Total RNAs were first digested by using Ribonuclease R to ensure the specific and efficient labeling 176 of cirRNA. Then, Cy3-dCTP was used to label cDNA in accordance with Eberwine's linear RNA 177 amplification method. The succeeding enzymatic reaction was as described above. The next steps of 178
RNA amplification, labeling, and hybridization are described in the "Agilent human lncRNA+mRNA 179
Array v4.0" section. 180
Microarray imaging and sample analysis 181
The Agilent GeneSpring software V13.0 was used to summary, normalize and control in quality the 182 data of the lncRNA+mRNA array, miRNA array, and circRNA array. 183
The genes which were differentially expressed were selected by using the Threshold values of ≥2 184 and ≤−2-fold change and a corrected P value of Benjamini-Hochberg, less than 0.05, which had 185 significant differences. Log2 was used to process the data and the CLUSTER 3.0 software was used 186
to adjust the data. The hierarchical clustering was used to analyze the data and cluster heat maps were 187 generated. At last, the Java TreeView (Stanford University School of Medicine, Stanford, CA, USA) 188 was used to conduct the tree visualization. On the basis of the normalized data, the Pearson 189 correlation coefficient matrix of the correlation between samples was made. The box plot was drawn, 190
showing the gene expression of different samples before and after data normalization. Principal 191 component analysis (PCA) was used to reflect the similarity of samples, and the expression of the 192 samples was shown in the 3D space through the dimension reduction of data. 193
Comparative analysis of case and control groups 194
T-test was used to analyze the difference between groups. The default screening criteria for 195 significant difference in this study were as follows: when the gene was upregulated, the number of 196 detected samples required to account for more than 60% of the total number of this group. When the 197 gene was downregulated, the requirement was the same. The difference multiple FC(ABS)≥2.0 and 198
P≤0.05 were also required. The larger the difference between the multiple of FC (ABS), the greater 199 the difference between the two groups. The lower the P value, the higher the reliability of differential 200 genes. Cluster analysis was performed, and a scatter map and volcano map were drawn to illustrate 201 the differences between groups. 202
Construction of the coding-noncoding gene co-expression (CNC) network 203
Construction of the lncRNA-mRNA network 204
The correlation analysis between the lncRNA and mRNA differentially expressed was used for 205
constructing the network of CNC. For construction of the network, , Pearson correlation was 206 calculated, and the critical correlation lncRNA and mRNA pairs were chosen. When Pearson 207 correlation coefficients, which are not less than 0.99, the lncRNAs and mRNAs pairswere selected to 208 draw the network by using software Cytoscape. In the network construction analysis, a degree was 209 the simplest and most important measure of a gene centrality which was defined as the number of 210 connections between one node to the other(BARABASI AND OLTVAI 2004). 211
The lncRNA prediction for Cis-acting and trans-acting was performed in this study. The was used for constructing the network. 229
Gene annotation and enrichment analysis 230
Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, 231
and disease analyses were conducted for the target gene mRNA of significantly different lncRNAs, 232 miRNAs, and circRNAs. In the KEGG pathway enrichment and disease analyses, the first 20 233 critically enriched GO terms were selected, and the first 20 significantly enriched terms from 234 biological process (BP), molecular function (MF), and cellular component (CC) were selected in GO. 235
The histogram drawn on the basis of the P value could directly reflect significantly enriched terms. A 236 bubble chart was also provided to show the enrichment analysis results. Finally, candidate signal 237 pathways related to TOF were used to further determine candidate lncRNAs, mRNAs, miRNAs, and 238 circRNAs. 239
Quantitative real-time polymerase chain reaction (qRT-PCR) 240
The RNA was extracted by using the TRIzol method, which was reverse, transcribed to cDNA by 241 using a TaKaRa reverse transcription kit. Reaction amplification was performed by using ABI 242
StepOne Real- 1 and 2). The clustering analysis result (Fig.1) suggests that in-group samples have a good correlation 257 and high consistency, whereas the between-group samples are significantly different and can be 258 clearly distinguished. Thus, the selection feasibility of tissue samples is high. Co-expression analysis 259 was conducted on the selected lncRNAs that are differentially expressed and mRNAs. A co-260 expression network map was constructed (Fig. 2) , and 44 lncRNAs and 497 mRNAs co-expressed 261 were identified. The target genes of the co-expressed lncRNA and mRNA were predicted, and the co-262 expression network map was constructed ( Fig. 3) . Finally, 66 lncRNAs and 62 mRNAs that may 263 target each other were identified. 264 GO, KEGG pathway enrichment, and disease analyses were conducted for the candidate genes 265 that target each other. In GO analysis, 20 significantly enriched terms were selected from BP, MF, 266 and CC. A histogram was drawn on the basis of the P value, as shown in Fig. 4 . In KEGG pathway 267 enrichment and disease analyses, a histogram was drawn for the top 20 terms, as shown in Fig. 5 . A 268 total of five lncRNAs and mRNAs that interacted with one another were selected finally (Table 1) . 269 miRNA 270 A total of 118 differentially expressed miRNAs, including 94 upregulated and 26 downregulated 271 miRNAs, were screened (Attached List 3). A Circos plot was drawn on the basis of the differences 272 (Fig. 6 ). This plot shows the degree of difference among genes on the basis of their location. Figure 6  273 shows 37 upregulated miRNAs and 10 downregulated miRNAs with a high degree of difference. The 274 number 13, 15, and Y chromosomes are not distributed. Clustering analysis and principal component 275 analysis suggest that in-group samples have a good correlation and a high consistency. The between-276 group samples are significantly different and can be clearly grouped, with strong data reliability. GO, 277 KEGG pathway enrichment, and disease analyses were conducted for different genes (Figs. 7 and 8) . 278 Target gene prediction was conducted for differential miRNA. miRNAs that interacted with another 279 and conformed to the expression trend of the target mRNA were selected (Table 2) . 280 circRNA 281 A total of 18,016 circRNAs which are differentially expressed, including 9404 upregulated circRNAs 282 and 8612 downregulated circRNAs, were screened. On the basis of differences, a Circos plot was 283 drawn (Fig. 9 ). This plot is based on the location of genes. It can show the degree of difference 284 between differential genes. The plot was distributed in all chromosomes. Clustering analysis and 285 PCA were conducted for cases and control samples. The results show that in-group samples have a 286 good correlation and high consistency; between-group samples are significantly different and can be 287 clearly grouped, and data have strong reliability. GO, KEGG pathway enrichment, and disease 288 analyses were conducted for differential circRNAs (Figs. 10 and 11) . The most prominent function of 289 circRNAs is its role as miRNA sponge to regulate target gene expression by inhibiting miRNA 290 activity. A circRNA-miRNA network was constructed (Fig. 12) . The figure shows the interaction 291 network between the first eight circRNAs and multiple target miRNAs. In these eight circRNAs, 292 except for hsa_circ_0056861_CBC1, the expression of the remaining circRNAs was downregulated 293 compared with that in the control group. Three differentially expressed circRNAs, namely, hsa-294 circRNA301, hsa_circ_0113626, and hsa_circ_0129079, may be related with the target mRNA and 295
were selected. The target mRNA of hsa-circRNA301 and hsa_circ_0113626 is CPT2, and that of 296 hsa_circ_0129079 is GHR. 297
qRT-PCR 298
qRT-PCR was conducted for the five pairs of candidate lncRNA/mRNAs in the case and control 299
groups. The test result shows that the relative quantitative analysis results of four lncRNAs and four 300 mRNAs are consistent with the chip results (Fig. 13 ). The four differential candidate lncRNAs are 301 ASO1873, ENST00000452466.1, NR_073058.1, and uc002qim.1, except for ENST00000517747.1. 302
The four differential mRNAs include QRSL1 (NM_018292), CPT2 (NM_000098), GHR 303 (NM_000163), and ZAK (NM_133646), except for MRPS18C (NM_016067 intergenic lncRNAs, are lacking. Given the diversity in the categories and functions of lncRNAs, the 335 reference significance of study results on different lncRNAs is not high. In addition, given the lack of 336 conservation among species, the expression level is generally low. There is no uniform name for 337 lncRNA characteristics in the world, so there is difficulty in understanding its real meaning and 338 function from the name. Given the absence of an lncRNA database, studying lncRNAs is difficult. 339
Moreover, the role of lncRNAs in heart development should be elucidated. With progress in this 340 field, many circRNAs have been identified to be distributed in many organisms; an evolutionarily 341 conserved endogenous ncRNA was found to play a crucial part in the regulation of gene expression 342
and and 8612 downregulated circRNAs, were screened. Target miRNA interaction analysis was 399 conducted for the first eight circRNAs, and the interactive network was constructed for further 400 studies. We could not observe the interaction of circRNA with uc002qim.1, ZAK, and miR-130b-3p. 401
cirRNA may have an effect on heart development through other unknown pathways. 402
In summary, the patterns of expression of lncRNAs, mRNAs, miRNAs, and circRNAs in the 403 RVOT of patients with TOF were studied using Agilent human lncRNA+mRNA Array v4.0, Agilent 404 human miRNA Array V21.0, and Agilent human circRNA Array v2.0. In this paper, the full 405 transcriptome data of RVOT myocardial tissue among patients with TOF were systematically 406 reported for the first time, and differentiation, GO, KEGG pathway enrichment, and target gene 407 prediction analyses were conducted to obtain these data. Finally, the optimal RNA sequencing 408 information was provided. As such, the function of these ncRNAs, their molecular regulatory 409 mechanisms, and their pathological mechanism in the occurrence and development of simple TOF 410 can be analyzed. Given sample size limitations, this study should be further strengthened. The 411 function and regulatory mechanism of ncRNAs should be further studied. 412
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